The present mini-commentary on Alzheimer's disease describes recently revealed pathogenic elements, evolving capabilities for identifying unusually high individual susceptibility and developing tests that predict onset preclinically to allow preventative approaches. Several potential therapies that target cellular signaling and other pathways that are abnormal in Alzheimer's disease are in early clinical trials and will be reviewed briefly.
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Volume 134, 30 August 2024
This paper analyzes Danish population data to identify and compare three distinct transgender subpopulations: those who changed their legal sex, those with trans-related medical diagnoses, and those who self-identify as transgender in surveys, revealing significant differences in socioeconomic and health outcomes among them. It highlights that transgender individuals seeking medical or legal transition face greater disadvantages, and that survey-based estimates do not fully capture the diversity or needs of the transgender population.
More than 1100 people came together virtually on 18 June 2024 for the tenth edition of the RELX SDG Inspiration Day: "In the Age of AI: Information to Advance the UN Sustainable Development Goals (SDGs)." The annual online event brings together thought leaders, corporate representatives, students, investors, governments, and NGOs to explore pressing issues, gain practical insight, and inspire action on the United Nations Sustainable Development Goals (SDGs).
This study reveals that the estimation of lipids and carotenoid levels could support the early diagnosis or help to understand the pathophysiology of Alzheimer's Disease.
Recognising our customers' exceptional work to achieve the UN Sustainable Development Goals.
